| 英文别名 |
2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide;4-HYDROXY-2-OXOPYRROLIDINE-N-ACETAMIDE;4-hydroxy-2-oxo-1-pyrrolidineacetamid;4-hydroxy-2-oxo-1-pyrrolidineacetamide;4-hydroxypiracetam;ct-848;hydroxypiracetam;isf2522;2-(4-HYDROXY-PYRROLIDINO-2-ON-1-YL)ETHYL ACETATE;4-1-lydroxypiracetan;Neuractiv;Neurome;(S)-2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide;(S)-OXIRACETAM;Oxiracetam;Oxriacetam;2-(4-Hydroxy-2-oxo-1-pyrrolidinyl)acetamide;Neuromet;ISF 2522;Oxiracetam(Random Configuration);(+-)-Oxiracetam;1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-;CGP 21690E;Oxiracetamum [INN-Latin];(+-)-4-Hydroxy-2-oxo-1-pyrrolidineacetamide;1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (+;ISF2522;4-Hydroxy-2-oxopyrrolidine-N-acetamide;NCGC00015768-04;4-Hydroxy-2-oxo-1-pyrrolidineacetamide;OXIRACETAM [JAN];62613-82-5;FT-0673343;NCGC00015768-07;OXIRACETAM [MART.];O0398;A21970;Q415099;CHEBI:134788;OXIRACETAM [MI];4-HYDROXY-2-OXO-PYRROLIDINACETAMIDE;R-Oxiracetam; (R)-ISF-2522;(R)-(+)-Oxiracetam;4-hydroxypyrrolidin-2-on-1-yl acetamide;DB13601;P7U817352G;ISF-2522;AC-670;CCG-205014;D07346;Hydroxypiracetam;NCGC00094242-01;O 3011;Q-201526;oxiracetam;DTXSID9045180;AKOS013252523;SR-01000076046-1;HMS3652J06;SW220157-1;Z1178486698;NCGC00094242-02;BCP31146;2-(4-hydroxypyrrolidin-2-on-1-yl) acetamide;Tox21_500933;CGP-21690E;IHLAQQPQKRMGSS-UHFFFAOYSA-N;Oxiracetam (INN);AMY5769;Oxiracetam [INN:BAN];BCP06209;HY-B1715;NCGC00015768-02;NCGC00015768-03;CT-848;BRN 1529719;2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide;CHEMBL36633;SDCCGSBI-0050907.P002;4-hydroxy-2-oxopyrrolidin-1-yl-acetamide;SR-01000076046;1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (+-)-;EN300-75437;GNF-PF-1005;4-Hydroxypiracetam;NS00122220;FT-0673341;CCRIS 4221;OXIRACETAM [WHO-DD];Tox21_110218;Lopac0_000933;A861378;2-(4-HYDROXY-2-OXO-1-PYRROLIDINYL)ACETAMIDE;SCHEMBL526050;CS-8012;OXIRACETAM [INN];DTXCID7025180;s4270;LP00933;oxiractam;MFCD00242951;CS3412;Oriest;CAS-62613-82-5;AB05478;HMS3262L08;FT-0630731;UNII-P7U817352G;HMS3885B17;NCGC00261618-01;EU-0100933;Oxiracetamum;AS-11801 |
